PATENT CLAIM ANALYSIS

Application Number: 16156418
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-04
Patent Classification: ["424", "001730"]

Abstract:
The present invention provides a method for selective delivery of a therapeutic or diagnostic agent to a targeted organ or tissue by implanting a biocompatible solid support in the patient being linked to a first binding agent, and administering a second binding agent to the patient linked to the therapeutic or diagnostic agent, such that the therapeutic or diagnostic agent accumulates at the targeted organ or tissue.

Claim (Index 42):
The method of  claim 30 , wherein the support composition comprises optionally modified alginate.

Metadata:
- Claim Count in Document: 41.0
- Percentile: 97.0
- Lexical Diversity: 1.79487
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15382402', '15265158', '14899041', '13877725', '14407300']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7737606858978038
- 35 USC 102 Novelty (BERT): 0.5637040072774907
- Combined Prediction Score: 0.7527550180357725
- Mean Citation Score: 350.808878
- Max Citation Score: 545.0407
- Similarity Product: 277.42549071056845

Labels:
- Claim Label 101: 0
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test